Effect of Granulocyte Colony-Stimulating Factor Combination Therapy on Efficacy of Posaconazole (SCH56592) in an Inhalation Model of Murine Pulmonary Aspergillosis

Using an inhalation model of pulmonary aspergillosis, we observed modest differences in the survival rates of mice treated with granulocyte colony-stimulating factor (G-CSF) and posaconazole (POS) and those treated with POS alone. This finding is in contrast to a previous report that suggested that...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Patera, Andriani C., Menzel, Frederick, Jackson, Craig, Brieland, Joan K., Halpern, Judy, Hare, Roberta, Cacciapuoti, Anthony, Loebenberg, David
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2004
Matèries:
Experimental Therapeutics
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC478512/
https://ncbi.nlm.nih.gov/pubmed/15273138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.8.3154-3158.2004
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars